Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.
about
Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyRedox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and PodocytesAutophagy in kidney health and disease.FOXO transcription factors: their clinical significance and regulation.Role of transcription factor acetylation in diabetic kidney disease.Induction of retinol dehydrogenase 9 expression in podocytes attenuates kidney injury.The Role of SIRT1 in Diabetic Kidney Disease.Renal protective effect of sirtuin 1Autophagy in diabetic nephropathyα-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetesBAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic miceSirtuin 1: A Target for Kidney Diseases.Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes.CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys.Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathyAnti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy.Sirtuin and metabolic kidney disease.Reduction in podocyte SIRT1 accelerates kidney injury in aging mice.Deep proteome mapping of mouse kidney based on OFFGel prefractionation reveals remarkable protein post- translational modifications.In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells.Admixture Mapping Identifies an Amerindian Ancestry Locus Associated with Albuminuria in Hispanics in the United States.Comment on "Renal Protective Effect of Sirtuin 1".Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.Theobromine increases NAD⁺/Sirt-1 activity and protects the kidney under diabetic conditions.Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes.Genome-wide association studies of albuminuria: towards genetic stratification in diabetes?Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1α signaling.FoxO4 promotes myocardial ischemia-reperfusion injury: the role of oxidative stress-induced apoptosisSIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
P2860
Q26744442-EA2E8B68-CB68-42C9-892E-C6B46C22B831Q26778527-CF4C75AD-466B-41BF-8679-C899E5B4FE33Q27687496-B6DB1737-145F-4B31-8257-1E988C68E661Q33594004-C5336401-FCCF-4E11-A130-48659145DFFAQ33789303-18E6C73C-7E3D-4B7E-A788-6ACD273D72C4Q34103512-1CD0C484-9663-46B2-B541-84345703CA16Q34312543-F8A923B1-D811-427D-B194-8F98D30F3C19Q34425883-E13C86C5-2FB6-45DF-B7EF-34F8F3BCD124Q34445143-C0D71D47-2F82-4FE7-B278-C9F9F27A7EB4Q35138684-060FFFD4-EF5C-47ED-A76E-30ACEA99B479Q35630822-481E0668-0F99-47CE-986D-570C93061D7AQ35707150-CA302C57-7671-4ABA-A1A3-1793FA2A3CFEQ35903079-520EC667-871C-4281-85C2-40303D8CE303Q35923790-2389B1BE-C598-4C55-A302-9B8A9FB6A46EQ36104788-875F4ABE-8BB9-4A07-BA1E-92A69648B1C4Q36304756-5105FCE2-A4AE-471D-B238-D57F32D6C1F6Q37260645-1DA64302-A4C7-4BA4-8A4C-46E2073D850DQ37571627-F54F0234-719A-4CAC-A46C-F19C7EE1C4DEQ38077692-E8CDF81E-5456-4802-90E0-0E8D4F96E057Q38530302-BCC09FBF-2F17-4001-98A5-90553D457FE5Q38725456-3CFCB749-C4EA-4559-9EFD-535239C614C9Q38863000-DD62978F-BCBF-49A2-B139-31332456FE14Q38982409-E69A78FD-D0D0-4D31-8C25-BBD9CABC4209Q40358583-8C56D57B-A2EE-4719-9D0E-202A42739A5DQ41403273-64303E59-176E-414A-BC6C-611B0E5A449AQ45967429-DBD63E4D-7B75-4A02-AC82-8436DF83A09EQ46312225-7727B2B4-8243-4DDF-94C3-8412BCD6CF87Q46812245-1FB45868-4C33-4EB4-9B7C-3590D9072AB2Q47117829-F5AE521E-0729-405C-B28E-8D198E2EC914Q47944978-43EA93B4-3219-4D19-A03B-3CF5EBC5F426Q51748134-81ED2808-06C0-4AFE-BDD4-399F6B863E22Q52560221-021FFB04-BC8D-45D2-A31A-F3D1242A9272Q57493375-C448BDA9-DAF1-472F-8F44-4CEE06E0042BQ58606256-657B5905-38F3-4F8B-BB2C-94D9DE9A5EB6
P2860
Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@ast
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@en
type
label
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@ast
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@en
prefLabel
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@ast
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@en
P2093
P2860
P1433
P1476
Alteration of forkhead box O ( ...... odocytes in diabetes mellitus.
@en
P2093
Belinda Jim
Clemens D Cohen
Matthias Kretzler
Peter Y Chuang
Ruijie Liu
P2860
P304
P356
10.1371/JOURNAL.PONE.0023566
P407
P577
2011-08-17T00:00:00Z